DK2151429T3 - Fremgangsmåde til fremstilling af agomelatin - Google Patents

Fremgangsmåde til fremstilling af agomelatin

Info

Publication number
DK2151429T3
DK2151429T3 DK09290607.2T DK09290607T DK2151429T3 DK 2151429 T3 DK2151429 T3 DK 2151429T3 DK 09290607 T DK09290607 T DK 09290607T DK 2151429 T3 DK2151429 T3 DK 2151429T3
Authority
DK
Denmark
Prior art keywords
agomelatine
preparation
Prior art date
Application number
DK09290607.2T
Other languages
English (en)
Inventor
Christophe Hardouin
Jean-Pierre Lecouve
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK2151429T3 publication Critical patent/DK2151429T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/02Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/08Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/72Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
    • C07C235/76Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C07C235/78Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings
DK09290607.2T 2008-08-05 2009-08-04 Fremgangsmåde til fremstilling af agomelatin DK2151429T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0804464A FR2934855B1 (fr) 2008-08-05 2008-08-05 Nouveau procede de synthese de l'agomelatine

Publications (1)

Publication Number Publication Date
DK2151429T3 true DK2151429T3 (da) 2011-09-19

Family

ID=40409856

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09290607.2T DK2151429T3 (da) 2008-08-05 2009-08-04 Fremgangsmåde til fremstilling af agomelatin

Country Status (46)

Country Link
US (1) US8143449B2 (da)
EP (1) EP2151429B1 (da)
JP (1) JP5021004B2 (da)
KR (1) KR101127357B1 (da)
CN (1) CN101643431B (da)
AP (1) AP2509A (da)
AR (1) AR074887A1 (da)
AT (1) ATE510816T1 (da)
AU (1) AU2009202905B2 (da)
BR (1) BRPI0903045A2 (da)
CA (1) CA2674764C (da)
CL (1) CL2009001632A1 (da)
CR (1) CR10934A (da)
CU (1) CU23858B1 (da)
CY (1) CY1111573T1 (da)
DK (1) DK2151429T3 (da)
EA (1) EA017684B1 (da)
EC (1) ECSP099549A (da)
ES (1) ES2367236T3 (da)
FR (1) FR2934855B1 (da)
GE (1) GEP20115344B (da)
GT (1) GT200900218A (da)
HK (1) HK1141004A1 (da)
HN (1) HN2009001435A (da)
HR (1) HRP20110568T1 (da)
IL (1) IL199875A (da)
JO (1) JO2821B1 (da)
MA (1) MA31830B1 (da)
ME (1) ME00927B (da)
MX (1) MX2009007971A (da)
MY (1) MY144746A (da)
NI (1) NI200900152A (da)
NZ (1) NZ578381A (da)
PE (1) PE20100259A1 (da)
PL (1) PL2151429T3 (da)
PT (1) PT2151429E (da)
RS (1) RS51740B (da)
SA (1) SA109300498B1 (da)
SG (1) SG158814A1 (da)
SI (1) SI2151429T1 (da)
SV (1) SV2009003344A (da)
TW (1) TWI376365B (da)
UA (1) UA106195C2 (da)
UY (1) UY31985A (da)
WO (1) WO2010015746A1 (da)
ZA (1) ZA200905051B (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2011001405A1 (es) 2010-06-10 2012-03-30 Gador S A Conicet Procedimiento para la preparacion de n-[2-(7-metoxi-1-naftil)etil]acetamida, agometalina.
CN102531956B (zh) * 2010-12-21 2014-07-09 浙江九洲药业股份有限公司 用于制备阿戈美拉汀的中间体及相关制备方法
US8561395B2 (en) 2011-03-03 2013-10-22 Tenneco Automotive Operating Company Inc. Poka-yoke mounting system for an exhaust treatment device
EP2562151A1 (en) * 2011-08-25 2013-02-27 Dr. Reddy's Laboratories Ltd. Processes for the preparation of agomelatine and its intermediates
ITMI20121444A1 (it) 2012-08-27 2014-02-28 Procos Spa Processo per la produzione di agomelatine
FR3014437B1 (fr) * 2013-12-05 2016-12-23 Servier Lab Nouveau procede de synthese de l'agomelatine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2658818B1 (fr) * 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
WO1996007635A1 (fr) * 1994-09-06 1996-03-14 Shionogi & Co., Ltd. Procede de production de derive d'alcoxyiminoacetamide
FR2734816B1 (fr) * 1995-05-31 1997-07-04 Adir Nouveaux aryl (alkyl) propylamides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2866335B1 (fr) * 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese de l'agomelatine

Also Published As

Publication number Publication date
FR2934855A1 (fr) 2010-02-12
MA31830B1 (fr) 2010-11-01
EA017684B1 (ru) 2013-02-28
CR10934A (es) 2009-10-15
HN2009001435A (es) 2011-12-27
MY144746A (en) 2011-10-31
JO2821B1 (en) 2014-09-15
JP2010043078A (ja) 2010-02-25
CN101643431B (zh) 2013-05-15
JP5021004B2 (ja) 2012-09-05
CN101643431A (zh) 2010-02-10
ZA200905051B (en) 2010-05-26
HK1141004A1 (en) 2010-10-29
CL2009001632A1 (es) 2010-07-19
CA2674764A1 (fr) 2010-02-05
CY1111573T1 (el) 2015-10-07
ES2367236T3 (es) 2011-10-31
NI200900152A (es) 2010-03-25
AP2509A (en) 2012-11-19
IL199875A0 (en) 2010-05-17
ATE510816T1 (de) 2011-06-15
PE20100259A1 (es) 2010-04-10
IL199875A (en) 2013-10-31
US8143449B2 (en) 2012-03-27
NZ578381A (en) 2010-11-26
EP2151429A1 (fr) 2010-02-10
AU2009202905A1 (en) 2010-02-25
CU20090131A7 (es) 2011-05-27
TWI376365B (en) 2012-11-11
EP2151429B1 (fr) 2011-05-25
KR20100017060A (ko) 2010-02-16
ECSP099549A (es) 2010-03-31
AU2009202905B2 (en) 2013-09-05
WO2010015746A1 (fr) 2010-02-11
PL2151429T3 (pl) 2011-11-30
SA109300498B1 (ar) 2013-07-23
HRP20110568T1 (en) 2011-09-30
UY31985A (es) 2010-01-29
AP2009004929A0 (en) 2009-08-31
BRPI0903045A2 (pt) 2010-05-25
KR101127357B1 (ko) 2012-04-12
PT2151429E (pt) 2011-07-11
EA200900943A1 (ru) 2010-04-30
SI2151429T1 (sl) 2011-09-30
ME00927B (me) 2012-06-20
MX2009007971A (es) 2010-03-25
US20100036163A1 (en) 2010-02-11
GEP20115344B (en) 2011-12-12
CA2674764C (fr) 2012-04-17
RS51740B (en) 2011-10-31
SV2009003344A (es) 2010-02-05
GT200900218A (es) 2010-08-23
AR074887A1 (es) 2011-02-23
UA106195C2 (ru) 2014-08-11
FR2934855B1 (fr) 2010-08-13
TW201018658A (en) 2010-05-16
CU23858B1 (es) 2013-02-26
SG158814A1 (en) 2010-02-26

Similar Documents

Publication Publication Date Title
DK2086944T3 (da) Fremgangsmåde til fremstilling af difluormethylpyrazolylcarboxylater
DK2220021T3 (da) Fremgangsmåde til fremstilling af terephtalsyre
DK2155838T3 (da) Fremgangsmåde til fremstilling af forgrenede carbonhydrider
DK2285779T3 (da) Fremgangsmåde til fremstilling af arylcarboxamider
DK2431359T3 (da) Fremgangsmåde til fremstilling af diaminophenothiaziniumforbindelser
DK2114886T3 (da) Fremgangsmåde til fremstilling af visse substituerede sulfiliminer
DK2310437T3 (da) Fremgangsmåde til kontinuerlig fremstilling af polyestere
DK2114853T3 (da) Fremgangsmåde til fremstilling af glycerolestere
DK2593449T3 (da) Fremgangsmåde til syntese af benzothiadiazolforbindelse
DK2151427T3 (da) Ny fremgangsmåde til syntetisering af agomelatin
DK2209900T3 (da) Anvendelse af bakterier til fremstillingen af bioenergi
DK3301074T3 (da) Fremgangsmåde til fremstilling af aluminiumphosphat
DK2119791T3 (da) Fremgangsmåde til fremstilling af flerumættede fedtsyrer
DK2151428T3 (da) Ny fremgangsmåde til syntese af agomelatin
DK2382232T3 (da) Fremgangsmåde til fremstilling af bivalirudin
DK3299356T3 (da) Fremgangsmåde til fremstilling af pleuromutiliner
DK2311970T3 (da) Fremgangsmåde til fremstillingen af bioprodukter
DK2627656T3 (da) Fremgangsmåde til fremstilling af dihydropteridinon og intermediater deraf
DK2307445T3 (da) Fremgangsmåde til fremstilling af caspofungin og mellemforbindelser heraf
DK2253608T4 (da) Fremgangsmåde til fremstilling af forgrenede mættede kulbrinter
DK2151429T3 (da) Fremgangsmåde til fremstilling af agomelatin
DK2516359T3 (da) Fremgangsmåde til fremstilling af ethylbenzen
DK2493860T3 (da) Fremgangsmåde til fremstilling af 4-sulfinylpyrazolderivater
DK2245000T3 (da) Fremgangsmåde til fremstilling af optisk aktive alfa-aminoacetaler
FI20085807A0 (fi) Menetelmä essitalopraamin valmistamiseksi